Biomarin Pharmaceutical (NASDAQ:BMRN) is set to give its latest quarterly earnings report on Monday, 2026-02-23. Here’s what investors need to know before the announcement.
Analysts estimate that Biomarin Pharmaceutical will report an earnings per share (EPS) of $0.41.
Biomarin Pharmaceutical bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings History Snapshot
During the last quarter, the company reported an EPS missed by $0.39, …